KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares RepurchasedShort-Term Debt repayments
Ratios

Elevance Health (ELV) Receivables - Net (2016 - 2025)

Elevance Health (ELV) has disclosed Receivables - Net for 17 consecutive years, with $9.5 billion as the latest value for Q3 2025.

  • On a quarterly basis, Receivables - Net rose 32.27% to $9.5 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $9.5 billion, a 32.27% increase, with the full-year FY2024 number at $8.0 billion, up 1.38% from a year prior.
  • Receivables - Net was $9.5 billion for Q3 2025 at Elevance Health, down from $10.5 billion in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $10.5 billion in Q2 2025 to a low of $5.7 billion in Q4 2021.
  • A 5-year average of $7.7 billion and a median of $7.4 billion in 2023 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: dropped 8.55% in 2024, then skyrocketed 32.27% in 2025.
  • Elevance Health's Receivables - Net stood at $5.7 billion in 2021, then grew by 24.68% to $7.1 billion in 2022, then grew by 11.56% to $7.9 billion in 2023, then increased by 1.38% to $8.0 billion in 2024, then increased by 19.02% to $9.5 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Receivables - Net are $9.5 billion (Q3 2025), $10.5 billion (Q2 2025), and $10.4 billion (Q1 2025).